Budapest, Hungary

Agnes Patthy Nee Lukats


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Agnes Patthy Nee Lukats: Innovator in CNS Activity Derivatives

Introduction

Agnes Patthy Nee Lukats is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of chemistry, particularly in the development of compounds with central nervous system (CNS) activity. Her work has implications for various therapeutic applications.

Latest Patents

Agnes holds a patent for N4-Substituted tetrahydro-1,2,4-oxadiazin-5-one derivatives. This invention relates to new tetrahydro-1,2,4-oxadiazin-5-one derivatives that exhibit CNS activity. More specifically, the patent concerns new N.sup.4-substituted tetrahydro-1,2,4-oxadiazin-5-ones of the formula (1), wherein R.sup.2 is benzyloxycarbonyl or alkylcarbonyl containing 1 to 4 carbon atoms in the alkyl moiety, preferably acetyl. This innovation showcases her expertise in medicinal chemistry.

Career Highlights

Agnes is associated with Richter Gedeon Vegyeszeti Gyar Rt., a prominent pharmaceutical company in Hungary. Her role at the company has allowed her to focus on research and development in the field of pharmaceuticals, contributing to advancements in drug formulation and efficacy.

Collaborations

Throughout her career, Agnes has collaborated with esteemed colleagues such as Laszlo Urogdi and Lajos Kisfaludy. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Agnes Patthy Nee Lukats is a distinguished inventor whose work in CNS activity derivatives has the potential to impact therapeutic practices significantly. Her contributions to the field of chemistry and her collaborations with other professionals highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…